Target intelligence / Profile preview

Collagen alpha-1(I) chain (COL1A1)

Target
COL1A1
Molecular classification
Extracellular matrix protein, Fibrillar collagen, Structural protein, Other
01

Overview

Collagen alpha-1(I) chain (COL1A1) is a major structural component of type I collagen, the most abundant fibrillar collagen in the human body, primarily found in bones, skin, tendons, and other connective tissues. Type I collagen typically exists as a heterotrimer composed of two alpha-1 chains (encoded by COL1A1) and one alpha-2 chain (encoded by COL1A2). COL1A1 plays a fundamental role in maintaining tissue structural integrity, cell morphology, and extracellular matrix (ECM) homeostasis. In pathological states, aberrant upregulation of COL1A1 is a hallmark of various fibrotic diseases, including idiopathic pulmonary fibrosis, liver cirrhosis, and systemic sclerosis, where excessive collagen deposition leads to organ dysfunction. Additionally, COL1A1 is highly expressed in the tumor microenvironment of several cancers (such as ovarian, pancreatic, and colorectal cancers), where it promotes tumor cell proliferation, invasion, chemoresistance, and immune evasion. Conversely, loss-of-function mutations in the COL1A1 gene are associated with genetic disorders such as osteogenesis imperfecta and Ehlers-Danlos syndrome. Therapeutic strategies targeting COL1A1 include small molecules like halofuginone, which specifically inhibits COL1A1 gene expression and collagen synthesis, as well as broader anti-fibrotic agents like pirfenidone and nintedanib that suppress collagen production by modulating upstream TGF-beta and tyrosine kinase signaling pathways.

Other names
Collagen type I alpha 1 chainAlpha-1 type I collagenPro-alpha-1(I) collagenCOL1A1Type I collagen alpha 1
02

Mechanism of action

Inhibition of COL1A1 gene transcription and translation, suppression of TGF-beta/Smad signaling pathway to reduce collagen synthesis, disruption of extracellular matrix deposition and collagen fibril assembly, and inhibition of mTOR/p70S6K pathway to suppress collagen production

03

Biological functions

Extracellular matrix organizationCell adhesionCell migrationSkeletal developmentTissue repairOther
04

Disease associations

CancerInflammationCardiovascular diseaseFibrosisOther
05

Safety considerations

Impaired wound healing and tissue repairIncreased risk of bone fractures or osteoporosisRisk of vascular fragility, bruising, or arterial dissectionOcular complications (e.g., corneal thinning, blue sclerae)Joint hypermobility or musculoskeletal soft tissue injuries
06

Interacting drugs

4 more in the full profile.

07

Biomarkers

COL1A1 mRNA expression levelsPro-collagen type I N-terminal propeptide (PINP)Pro-collagen type I C-terminal propeptide (PICP)Type I collagen cross-linked C-telopeptide (CTX)COL1A1 genetic variants (e.g., rs1800012 Sp1 binding site polymorphism)

Beyond the preview

Go deeper on Collagen alpha-1(I) chain (COL1A1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Collagen alpha-1(I) chain (COL1A1).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call